Specialties
Cardiology
Chronic Disease
Dermatology
Emergency
Endocrinology
Gastroenterology
Imaging and Intervention
Infectious Disease
Nephrology
Neurology
Obstetrics
Oncology
Ophthalmology
Pediatrics
Preclinical
Psychiatry
Public Health
Pulmonology
Surgery
Urology
Classics™
Rewinds
Click for the Rewinds Archive
Power Rankings™
Patients
Subscribe
Write for Us
Writer Application
Submit an Opinion
For Partners
License Content
Submit Press Release
Advertise with Us
Search
Wednesday, April 24, 2019
About
Masthead
License Content
Advertise
Submit Press Release
RSS/Email List
Write for us
Contact us
2 Minute Medicine
Specialties
All
Cardiology
Chronic Disease
Dermatology
Emergency
Endocrinology
Gastroenterology
Imaging and Intervention
Infectious Disease
Nephrology
Neurology
Obstetrics
Oncology
Ophthalmology
Pediatrics
Preclinical
Psychiatry
Public Health
Pulmonology
Surgery
Urology
Increased sedentary activity across all age groups in the United States
Quick Take: Safety and Feasibility of Using Magnetic Resonance Imaging Criteria…
Soft bedding, overlaying, wedging common causes of sleep-related infant death
Quick Take: Effect of Developmentally Adapted Cognitive Processing Therapy for Youth…
Classics™
Rewinds
2 Minute Medicine Rewind April 22, 2019
2 Minute Medicine Rewind April 15, 2019
2 Minute Medicine Rewind April 8, 2019
2 Minute Medicine Rewind April 1, 2019
2 Minute Medicine Rewind March 25, 2019
Click for the Rewinds Archive
Power Rankings™
Patients
Subscribe
Write for Us
Writer Application
Submit an Opinion
For Partners
License Content
Submit Press Release
Advertise with Us
Tag: givosiran
RNA interference agent givosiran appears safe in phase I trial
James Roebker
-
February 11, 2019
0
All-time hits
The Child-Pugh score: Prognosis in chronic liver disease and cirrhosis [Classics...
July 16, 2013
The CLOT trial: Dalteparin versus warfarin [Classics Series]
December 7, 2014
Updated JNC 8 guidelines for antihypertensive drugs released
December 19, 2013
